Serveur d'exploration SRAS - Exploration (Accueil)

Index « Titre (en) » - entrée « neutralizing »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
neutralizes < neutralizing < neutrophil  Facettes :

List of bibliographic references indexed by neutralizing

Number of relevant bibliographic references: 86.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000417 (2020) Guangyu Zhou [République populaire de Chine] ; Qi Zhao [République populaire de Chine]Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2
000709 (2020) Qingqing LinDuration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection
000D21 (2018) Renqiang Liu [République populaire de Chine] ; Jinliang Wang [République populaire de Chine] ; Yu Shao [République populaire de Chine] ; Xijun Wang [République populaire de Chine] ; Huilei Zhang [République populaire de Chine] ; Lei Shuai [République populaire de Chine] ; Jinying Ge [République populaire de Chine] ; Zhiyuan Wen [République populaire de Chine] ; Zhigao Bu [République populaire de Chine]A recombinant VSV-vectored MERS-CoV vaccine induces neutralizing antibody and T cell responses in rhesus monkeys after single dose immunization.
001005 (2016) Qidi Wang [République populaire de Chine] ; Lianfeng Zhang [République populaire de Chine] ; Kazuhiko Kuwahara [Japon] ; Li Li [République populaire de Chine] ; Zijie Liu [République populaire de Chine] ; Taisheng Li [République populaire de Chine] ; Hua Zhu [République populaire de Chine] ; Jiangning Liu [République populaire de Chine] ; Yanfeng Xu [République populaire de Chine] ; Jing Xie [République populaire de Chine] ; Hiroshi Morioka [Japon] ; Nobuo Sakaguchi [Japon] ; Chuan Qin [République populaire de Chine] ; Gang Liu [République populaire de Chine]Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates
001118 (2016) C. Geisen [Allemagne] ; G. Kann [Allemagne] ; T. Strecker [Allemagne] ; T. Wolf [Allemagne] ; G. Schüttfort [Allemagne] ; M. Van Kraaij [Pays-Bas] ; S. Maclennan [Royaume-Uni] ; S. Rummler [Allemagne] ; C. Weinigel [Allemagne] ; M. Eickmann [Allemagne] ; S. K. Fehling [Allemagne] ; V. Kr Hling [Allemagne] ; C. Seidl [Allemagne] ; E. Seifried [Allemagne] ; M. Schmidt [Allemagne] ; R. Sch Fer [Allemagne]Pathogen‐reduced Ebola virus convalescent plasma: first steps towards standardization of manufacturing and quality control including assessment of Ebola‐specific neutralizing antibodies
001552 (2014) Ponraj Prabakaran [États-Unis] ; Weizao Chen [États-Unis] ; Dimiter S. Dimitrov [États-Unis]The Antibody Germline/Maturation Hypothesis, Elicitation of Broadly Neutralizing Antibodies Against HIV-1 and Cord Blood IgM Repertoires.
001564 (2014) Oi-Wing Ng [Singapour] ; Choong-Tat Keng [Singapour] ; Cynthia Sau-Wai Leung [République populaire de Chine] ; J S Malik Peiris [République populaire de Chine] ; Leo Lit Man Poon [République populaire de Chine] ; Yee-Joo Tan [Singapour]Substitution at aspartic acid 1128 in the SARS coronavirus spike glycoprotein mediates escape from a S2 domain-targeting neutralizing monoclonal antibody.
001786 (2014) Christopher M. Coleman [États-Unis] ; Ye V. Liu [États-Unis] ; HAIYAN MU [États-Unis] ; Justin K. Taylor [États-Unis] ; Michael Massare [États-Unis] ; David C. Flyer [États-Unis] ; Gregory M. Glenn [États-Unis] ; Gale E. Smith [États-Unis] ; Matthew B. Frieman [États-Unis]Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice
001832 (2013) Huihui Mou [Pays-Bas] ; V Stalin Raj ; Frank J M. Van Kuppeveld ; Peter J M. Rottier ; Bart L. Haagmans ; Berend Jan BoschThe receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies.
001877 (2013) Weixu Meng [République populaire de Chine] ; Weiqi Pan [République populaire de Chine] ; Anna J. X. Zhang [République populaire de Chine] ; Zhengfeng Li [République populaire de Chine] ; Guowei Wei [République populaire de Chine] ; Liqiang Feng [République populaire de Chine] ; Zhenyuan Dong [République populaire de Chine] ; Chufang Li [République populaire de Chine] ; Xiangjing Hu [République populaire de Chine] ; Caijun Sun [République populaire de Chine] ; Qinfang Luo [République populaire de Chine] ; Kwok-Yung Yuen [République populaire de Chine] ; Nanshan Zhong [République populaire de Chine] ; Ling Chen [République populaire de Chine]Rapid Generation of Human-Like Neutralizing Monoclonal Antibodies in Urgent Preparedness for Influenza Pandemics and Virulent Infectious Diseases
001A01 (2013) Guangyu Zhao [République populaire de Chine] ; Lanying Du ; Cuiqing Ma ; Ye Li ; Lin Li ; Vincent Km Poon ; Lili Wang ; Fei Yu ; Bo-Jian Zheng ; Shibo Jiang ; Yusen ZhouA safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV.
001C09 (2013) Kwok-Hung Chan [Hong Kong] ; Jasper Fuk-Woo Chan [Hong Kong] ; Herman Tse [Hong Kong] ; HONGLIN CHEN [Hong Kong] ; Candy Choi-Yi Lau [Hong Kong] ; Jian-Piao Cai [Hong Kong] ; Alan Ka-Lun Tsang [Hong Kong] ; XINCAI XIAO [République populaire de Chine] ; Kelvin Kai-Wang To [Hong Kong] ; Susanna Kar-Pui Lau [Hong Kong] ; Patrick Chiu-Yat Woo [Hong Kong] ; Bo-Jiang Zheng [Hong Kong] ; MING WANG [République populaire de Chine] ; Kwok-Yung Yuen [Hong Kong]Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests
001D12 (2012) Hatem A. Elshabrawy [États-Unis] ; Melissa M. Coughlin ; Susan C. Baker ; Bellur S. PrabhakarHuman monoclonal antibodies against highly conserved HR1 and HR2 domains of the SARS-CoV spike protein are more broadly neutralizing.
001D33 (2012) Kazuya Shirato ; Miyuki Kawase ; Oshi Watanabe [Japon] ; Chika Hirokawa [Japon] ; Shutoku Matsuyama ; Hidekazu Nishimura [Japon] ; Fumihiro Taguchi [Japon]Differences in neutralizing antigenicity between laboratory and clinical isolates of HCoV-229E isolated in Japan in 2004-2008 depend on the S1 region sequence of the spike protein.
001E57 (2012) Melissa M. Coughlin [États-Unis] ; Bellur S. Prabhakar [États-Unis]Neutralizing human monoclonal antibodies to severe acute respiratory syndrome coronavirus: target, mechanism of action, and therapeutic potential
001E75 (2012) Nguyen-Xuan Huy [Corée du Sud, Viêt Nam] ; Sae-Hae Kim [Corée du Sud] ; Moon-Sik Yang [Corée du Sud] ; Tae-Geum Kim [Corée du Sud]Immunogenicity of a neutralizing epitope from porcine epidemic diarrhea virus: M cell targeting ligand fusion protein expressed in transgenic rice calli
002083 (2011) Lifeng Liu [République populaire de Chine] ; Jing Xie ; Jianpin Sun ; Yang Han ; Chao Zhang ; Hongwei Fan ; Zhengyin Liu ; Zhifeng Qiu ; Yuxian He ; Taisheng LiLongitudinal profiles of immunoglobulin G antibodies against severe acute respiratory syndrome coronavirus components and neutralizing activities in recovered patients.
002277 (2011) Yi-Ning Chen [États-Unis] ; Ching Ching Wu [États-Unis] ; Tsang Long Lin [États-Unis]Identification and characterization of a neutralizing-epitope-containing spike protein fragment in turkey coronavirus
002366 (2011) LIFENG LIU [République populaire de Chine] ; JING XIE [République populaire de Chine] ; JIANPIN SUN [République populaire de Chine] ; YANG HAN [République populaire de Chine] ; CHAO ZHANG [République populaire de Chine] ; HONGWEI FAN [République populaire de Chine] ; ZHENGYIN LIU [République populaire de Chine] ; ZHIFENG QIU [République populaire de Chine] ; YUXIAN HE [République populaire de Chine] ; TAISHENG LI [République populaire de Chine]Longitudinal profiles of immunoglobulin G antibodies against severe acute respiratory syndrome coronavirus components and neutralizing activities in recovered patients
002493 (2010) Jody D. Berry [États-Unis, Canada] ; Kevin Hay [États-Unis] ; James M. Rini [États-Unis] ; Meng Yu ; Linfa Wang ; Francis A. Plummer [États-Unis, Canada] ; Cindi R. Corbett [États-Unis, Canada] ; Anton Andonov [États-Unis, Canada]Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technology
002521 (2010) Lanying Du [États-Unis] ; Shibo Jiang [États-Unis]Immunotherapy of SARS based on combinations of neutralizing human monoclonal antibodies.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "neutralizing" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "neutralizing" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    neutralizing
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021